Development and RA

The Development Department at BTG is an integral part of the Ferring Global Pharmaceutical R&D organization

At BTG, our Development Department plays a vital role within Ferring’s Global Pharmaceutical R&D organization. We bring together all the essential capabilities to develop high-quality biopharmaceuticals—right from early-stage research through to clinical development. Our strategic location within BTG enables seamless technology transfer to Manufacturing and provides direct access to deep production expertise.

We specialize in developing Drug substance cGMP-compliant manufacturing processes and analytical methods for both bacterially-derived and mammalian cell culture-based recombinant proteins. These are used in pre-clinical and clinical studies, ensuring robust and reliable outcomes.

Beyond innovation, we are committed to supporting the lifecycle of existing Ferring products manufactured at BTG. Our team offers continuous support and lifecycle management, backed by extensive experience in navigating biopharmaceutical regulatory requirements in collaboration with both local and global partners

The BTG Regulatory Affairs Department is responsible for providing regulatory support to BTG commercial products and Ferring global recombinant products under development.